At the level of differentiation, the enhanced expression of PARK7 in MD/PD/WD metastatic OSCC compared to keratinized WD OSCC supports tumor progression and is correlated with a poor clinical outcome [26]. The gene discussed is PARK7; the disease is Wilson disease.